Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04191330 · ClinicalTrials.gov registry record · NA

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

A NA study of Heart Failure, sponsored by Biofourmis.

Active
Registry status
NA
Development phase
122
Enrollment target
14
Study locations

NCT04191330: Active NA study of Heart Failure, sponsored by Biofourmis.

NCT04191330 is a NA study of Heart Failure that is active but no longer recruiting, run by Biofourmis. The registered enrollment target is 122 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The trial reports 14 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04191330, a NA study of Heart Failure, is active but no longer recruiting, sponsored by Biofourmis.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
122 participants
Enrollment target
14
Study locations

Study Summary

The goal of this real-world, multi-center, randomized, outpatient study is to assess the effectiveness of the Biofourmis cloud based BiovitalsHF platform to recommend optimal titration of Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) subjects.

Conditions Studied

Heart Failure

Interventions

  • DEVICE BiovitalsHF

Study Locations (14)

Arkansas

  • Cardiology and Medicine Clinic - Little Rock

District of Columbia

  • Medstar Washington Hospital Center - Washington D.C.

Georgia

  • Piedmont Athens Regional Medical Center - Athens

Kentucky

  • Baptist Health Louisville Heart Failure Clinic - Louisville

Louisiana

  • Cambridge Medical Trials - Alexandria

Maryland

  • Medstar Union Memorial Hospital - Baltimore

Michigan

  • St Joseph Mercy - Ypsilanti

Mississippi

  • Jackson Heart - Jackson

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2020-01-27
Est. Completion 2024-08-31
Phase NA

Sponsor

Biofourmis

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04191330

The ClinicalTrials.gov registry entry for NCT04191330 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The listed sponsor is Biofourmis, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which BiovitalsHF is the first listed.

NCT04191330 reports 14 study locations spanning 14 distinct geographic areas - top geographies include Arkansas, District of Columbia, Georgia.

Frequently Asked Questions

What is clinical trial NCT04191330 about?

NCT04191330 is a clinical study titled "Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors". The goal of this real-world, multi-center, randomized, outpatient study is to assess the effectiveness of the Biofourmis cloud based BiovitalsHF platform to recommend optimal titration of Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) subjects.

What is the current status of trial NCT04191330?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 122 participants. The study started on 2020-01-27. Estimated completion is 2024-08-31.

What conditions does trial NCT04191330 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT04191330?

The interventions under investigation include: BiovitalsHF (DEVICE).

Who is sponsoring clinical trial NCT04191330?

This trial is sponsored by Biofourmis, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04191330 being conducted?

This trial has 14 study locations across Arkansas, District of Columbia, Georgia, Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.